NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Prescribing
  • Key to symbols

Search results for: oxycodone


4.7.2 Opioid analgesics

Preferred list
OXYCODONE HYDROCHLORIDE (oral formulations)

Restrictions:

Use is restricted to patients in whom morphine is ineffective or not tolerated. The injection is restricted to initiation by specialists in palliative care and oncology for use in patients for whom morphine/diamorphine is ineffective or not tolerated. Oxycodone injection is non-Formulary for post-operative use. The combination product of oxycodone and naloxone (Targinact®) is not recommended for use in NHS Scotland by the SMC and is non-Formulary.

Prescribing Notes:

Oral oxycodone preparations should be prescribed by brand name and the current brands of choice for modified-release and immediate release preparations respectively are Longtec® and Shortec®.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/85406.htm

View this Search Result »


4.7.2 Opioid analgesics

Total Formulary
OXYCODONE HYDROCHLORIDE (INJECTION)

Restrictions:

Oxycodone 10mg/ml injection is restricted to use in the treatment of moderate to severe pain in cancer in those patients who have difficulty in tolerating morphine or diamorphine therapy.

The 50mg/ml injection is further restricted to those patients who require either a high dose bolus injection (>2ml of the 10mg/1ml injection) of oxycodone, or oxycodone delivered via a continuous subcutaneous infusion where the use of the 10mg/ml injection would result in a total volume of all medicines which necessitates the use of an additional syringe pump.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/85406.htm

View this Search Result »